2008
Estimation of HIV Incidence in the United States
Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, Group F. Estimation of HIV Incidence in the United States. JAMA 2008, 300: 520-529. PMID: 18677024, PMCID: PMC2919237, DOI: 10.1001/jama.300.5.520.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV incidenceHIV infectionBED HIV-1 capture enzyme immunoassayIncidence of HIVNew infectionsPatients 13 yearsNew HIV infectionsPercent of infectionsClinic-based settingBlack individualsCapture enzyme immunoassayHIV diagnosisHIV casesImmunodeficiency virusRecent infectionIncidence rateMAIN OUTCOMEDiagnostic seraAIDS incidenceDisease controlInfectionEnzyme immunoassayIncidenceDiagnostic specimens
2001
Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. PMID: 11242178, DOI: 10.1097/00042560-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIVPublic Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
Tchetgen E, Kaplan E, Friedland G. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 118-129. DOI: 10.1097/00126334-200102010-00003.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyAntiretroviral therapyDrug resistanceDrug-resistant virusesNew HIV infectionsHIV antiretroviral therapyImportance of adherencePublic health consequencesHIV patientsHIV infectionTreatment regimensScreening patientsAIDS casesPatient benefitPhysician's abilityPatientsAIDS incidenceTherapyHealth consequencesAdherenceRecent studiesPopulation levelHAARTRegimensHIV
1998
Allocating HIV prevention resources
Kaplan E, Pollack H. Allocating HIV prevention resources. Socio-Economic Planning Sciences 1998, 32: 257-263. DOI: 10.1016/s0038-0121(98)00002-0.Peer-Reviewed Original Research
1995
HIV Incidence Among New Haven Needle Exchange Participants
Kaplan E, Heimer R. HIV Incidence Among New Haven Needle Exchange Participants. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 175-176. PMID: 7552482, DOI: 10.1097/00042560-199510020-00010.Peer-Reviewed Original Research
1993
How many drug injectors are there in New Haven? Answers from AIDS data
Kaplan E, Soloshatz D. How many drug injectors are there in New Haven? Answers from AIDS data. Mathematical And Computer Modelling 1993, 17: 109-115. DOI: 10.1016/0895-7177(93)90243-r.Peer-Reviewed Original Research